PFKFB4 Overexpression Facilitates Proliferation by Promoting the G1/S Transition and Is Associated with a Poor Prognosis in Triple-Negative Breast Cancer
Background. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphate-4 (PFKFB4) is a key factor that plays an important role in tumorigenesis. However, its role in triple-negative breast cancer (TNBC) progression needs to be further validated. We investigated whether PFKFB4 is directly involved in the onco...
Main Authors: | Yu-Chen Cai, Hang Yang, Hong-Bo Shan, Hui-Fang Su, Wen-Qi Jiang, Yan-Xia Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2021/8824589 |
Similar Items
-
CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer.
by: Mi Jeong Kwon, et al.
Published: (2015-01-01) -
High expression of metabolic enzyme PFKFB4 is associated with poor prognosis of operable breast cancer
by: Ling Yao, et al.
Published: (2019-06-01) -
B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
by: Ling Wang, et al.
Published: (2018-07-01) -
ANGPTL4 overexpression inhibits tumor cell adhesion and migration and predicts favorable prognosis of triple-negative breast cancer
by: Yu-Chen Cai, et al.
Published: (2020-09-01) -
The influence of PFK-II overexpression on neuroblastoma patients’ survival may be dependent on the particular isoenzyme expressed, PFKFB3 or PFKFB4
by: Sonia E. Trojan, et al.
Published: (2019-11-01)